Koyfin Home > Directory > Health Care > Boston Scientific Corp > EBIT

Boston Scientific Corp EBIT Chart (BSX)

Boston Scientific Corp annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Boston Scientific Corp EBIT for the quarter ending September 09, 2020 was $282m a -77.66% decrease of -219m year over year
  • Boston Scientific Corp EBIT for the last 12 months ending September 09, 2020 was $996m a -81.33% decrease of -810m year over year
  • Boston Scientific Corp Annual EBIT for 2019 was $1,806m a 4.54% increase of 82m from 2018
  • Boston Scientific Corp Annual EBIT for 2018 was $1,724m a 7.25% increase of 125m from 2017
  • Boston Scientific Corp Annual EBIT for 2017 was $1,599m a 13.01% increase of 208m from 2016
Other Income Statement Metrics:
  • Boston Scientific Corp EBITDA for the quarter ending December 12, 2018 was $716m a 9.08% increase of 65m year over year
  • Boston Scientific Corp Net Income for the quarter ending December 12, 2018 was $386m a 22.80% increase of 88m year over year
  • Boston Scientific Corp Total Revenue for the quarter ending December 12, 2018 was $2,561m a 7.11% increase of 182m year over year
View Chart On Koyfin

Quarterly BSX EBIT Data

09/2020$282m
06/2020$-33m
03/2020$246m
12/2019$501m
09/2019$419m
06/2019$447m
03/2019$438m
12/2018$476m
09/2018$397m
06/2018$426m

Annual BSX EBIT Data

2019$1,806m
2018$1,724m
2017$1,599m
2016$1,391m
2015$1,083m
2014$959m
2013$907m
2012$955m
2011$1,028m
2010$1,043m